NEW
โ ExplanationAdvancedIndustry Deep Dives โบ Healthcare & Pharma
Johnson & Johnson Reports Positive Early Results For Experimental Prostate Cancer Drug
Johnson & Johnson has announced promising early-stage clinical trial data for its experimental oral prostate cancer treatment, JNJ-6143. The drug, acquired through the company's multi-billion dollar purchase of Halda Therapeutics, showed significant tumor reduction in patients who had previously exhausted other treatment options.
2mยท๐ 0
โ Explanation๐ StandardBuildingIndustry Deep Dives โบ Company & Industry Analysis
Johnson & Johnson โ Healthcare Conglomerate and Dividend Aristocrat
J&J is one of only two U.S. corporations with a AAA credit rating and has paid increasing dividends for 62 consecutive years. Its story includes the Tylenol poisoning crisis, the talc litigation, and a landmark corporate split.
4mยท๐ 4